Consistent with previous researches in asthma, the functional rs37973 variant in GLCCI1 was first identified to cause substantial decrements in ICS therapeutic response in 935 white non-Hispanic adults and children by Tantisira et al. 12, and subsequently validated in 402 European asthmatic children9 and 224 Japanese adult patients7. Here, GLCCI1 is linked to asthma.